Evidence map›Paper›PMID 32343879›Full record

ArticleFEBS open bio2020

Reduced levels of miR-485-5p in HPV-infected cervical cancer promote cell proliferation and enhance invasion ability.

Yuanyuan Dai, Fengyan Xie, Yan Chen

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in FEBS open bio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Ythdc1-p300-Klf5 Complex-Mediated Golgi Dysfunction Promotes Aortic Aneurysm.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yuanyuan DaiDepartment of Obstetrics and Gynecology, the Third Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Fengyan XieDepartment of Obstetrics and Gynecology, the Third Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Yan ChenDepartment of Obstetrics and Gynecology, the Third Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.ORCID 0000-0001-9038-3903
Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer (CC) is the most common gynecological malignancy, with high incidence and mortality rates in China. The microRNA miR-485-5p has previously been reported to serve as a negative regulator of tumorigenesis in breast cancer and hepatocellular carcinoma, and miR-485-5p has been observed to be differentially expressed between CC and normal control tissue. Here, we confirmed that miR-485-5p expression is lower in CC than in adjacent normal tissue and proceeded to investigate the effects of miR-485 on tumor behavior in CC cell lines. We report that miR-485-5p transcription is decreased in HPV-infected CC tissue, and levels of miR-485 in clinical samples are positively correlated with the 5-year overall survival rate. The Transwell assay showed that miR-485-5p inhibited cell invasion and migration but had no influence on apoptosis and cell proliferation. Using a luciferase reporter assay, we demonstrated that miR-485-5p partially abrogated cell migration and proliferation by targeting FLOT-1 mRNA. Transfection of HPV-infected cervical carcinoma cells with an adenovirus vector encoding human FLOT-1 partially diminished the inhibitory effects of miR-485 on cell invasion. Taken, together, these data demonstrated that miR-485-5p suppresses the invasion of cancer cells by targeting FLOT-1 in HPV-infected cervical carcinoma cells.

Indexed as

Cell MovementCell ProliferationCells, CulturedFemaleGene Expression Regulation, NeoplasticHumansMicroRNAsPapillomavirus InfectionsUterine Cervical NeoplasmsMicroRNAsMIRN485 microRNA, humancell proliferationcervical cancerFLOT-1HPV-infectedinvasionmicroRNA-485-5p

Identifiers

PMID32343879
PMCPMC7327903
OpenAlexW3017486179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.